Home / GRK2 Knockout Cell Lines

GRK2 Knockout Cell Lines

Gene: GRK2

Official Full Name: G protein-coupled receptor kinase 2provided by HGNC

Gene Summary: This gene encodes a member of the G protein-coupled receptor kinase family of proteins. The encoded protein phosphorylates the beta-adrenergic receptor as well as a wide range of other substrates including non-GPCR cell surface receptors, and cytoskeletal, mitochondrial, and transcription factor proteins. Data from rodent models supports a role for this gene in embryonic development, heart function and metabolism. Elevated expression of this gene has been observed in human patients with heart failure and Alzheimer's disease. [provided by RefSeq, Sep 2017]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00312 GRK2 Knockout cell line(HEK293) Human GRK2 1:3~1:6 Negative Online Inquiry
KO10052 GRK2 Knockout cell line (HeLa) Human GRK2 1:3~1:6 Negative Online Inquiry
KO10053 GRK2 Knockout cell line (HCT 116) Human GRK2 1:2~1:4 Negative Online Inquiry
KO10054 GRK2 Knockout cell line (A549) Human GRK2 1:3~1:4 Negative Online Inquiry

Background

GRK2 Gene Knockout Cell Lines are specialized cellular models designed for the study of G protein-coupled receptor (GPCR) signaling and regulation. These cell lines have been genetically engineered to disrupt the GRK2 (G-protein-coupled receptor kinase 2) gene, resulting in the absence of protein expression. The key function of GRK2 in cellular signaling pathways involves the phosphorylation of activated GPCRs, which facilitates their desensitization and internalization. By utilizing these knockout cell lines, researchers can investigate the specific roles of GRK2 in various physiological and pathological processes.

In scientific research, GRK2 Gene Knockout Cell Lines are invaluable for elucidating the mechanisms underlying receptor-mediated signaling pathways. The absence of GRK2 allows for a clearer understanding of how GPCRs function without this regulatory protein, providing insights into drug action, receptor desensitization, and potential therapeutic targets in diseases such as heart failure, cancer, and neurological disorders. In clinical settings, this tool can aid the development of novel pharmacological strategies aimed at modulating GPCR signaling for therapeutic benefit.

One of the primary advantages of GRK2 Gene Knockout Cell Lines is their specificity and reproducibility compared to alternative models, such as chemical inhibitors or RNA interference approaches. The targeted gene knockout eliminates variability associated with transient knockdown methods, ensuring consistent results across experiments. This precision can significantly enhance the reliability of research findings, making these cell lines a superior choice for detailed mechanistic studies.

For researchers and clinicians, the value of GRK2 Gene Knockout Cell Lines lies in their capacity to facilitate groundbreaking discoveries that may lead to innovative treatments. By providing a robust platform for studying GPCR dynamics, these models can drive advancements in our understanding of cell signaling and its implications in health and disease.

Our company is dedicated to delivering top-tier biological research tools, including GRK2 Gene Knockout Cell Lines, backed by a team of experts in genetic engineering and cellular biology. We are committed to contributing to the scientific community by providing high-quality products that empower researchers to achieve their experimental goals.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.